Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea
<p>Abstract</p> <p>Background</p> <p>To evaluate efficacy in patients with brain metastasis (BM) on entry into the lapatinib expanded access program (LEAP).</p> <p>Methods</p> <p>LEAP is a worldwide, single-arm, open-label study. HER2-positive, l...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-07-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | http://www.biomedcentral.com/1471-2407/12/322 |